BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33801444)

  • 1. Clinical Significance of PDCD4 in Melanoma by Subcellular Expression and in Tumor-Associated Immune Cells.
    Tran TT; Rane CK; Zito CR; Weiss SA; Jessel S; Lucca L; Lu BY; Oria VO; Adeniran A; Chiang VL; Omay SB; Hafler DA; Kluger HM; Jilaveanu LB
    Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33801444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PLEKHA5 regulates tumor growth in metastatic melanoma.
    Zhang H; Zhu H; Deng G; Zito CR; Oria VO; Rane CK; Zhang S; Weiss SA; Tran T; Adeniran A; Zhang F; Zhou J; Kluger Y; Bosenberg MW; Kluger HM; Jilaveanu LB
    Cancer; 2020 Mar; 126(5):1016-1030. PubMed ID: 31769872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis.
    Jilaveanu LB; Parisi F; Barr ML; Zito CR; Cruz-Munoz W; Kerbel RS; Rimm DL; Bosenberg MW; Halaban R; Kluger Y; Kluger HM
    Clin Cancer Res; 2015 May; 21(9):2138-47. PubMed ID: 25316811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-L1, PD-1, LAG-3, and TIM-3 in Melanoma: Expression in Brain Metastases Compared to Corresponding Extracranial Tumors.
    Wang JJ; Burger P; Taube J; Soni A; Chaichana K; Sheu M; Belcaid Z; Jackson C; Lim M
    Cureus; 2019 Dec; 11(12):e6352. PubMed ID: 31938638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detailed spatial immunophenotyping of primary melanomas reveals immune cell subpopulations associated with patient outcome.
    Attrill GH; Lee H; Tasker AT; Adegoke NA; Ferguson AL; da Silva IP; Saw RPM; Thompson JF; Palendira U; Long GV; Ferguson PM; Scolyer RA; Wilmott JS
    Front Immunol; 2022; 13():979993. PubMed ID: 36003398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of PD-L1 Expression and Associated T-cell Infiltrates in Metastatic Melanoma Samples from Variable Anatomic Sites.
    Kluger HM; Zito CR; Barr ML; Baine MK; Chiang VL; Sznol M; Rimm DL; Chen L; Jilaveanu LB
    Clin Cancer Res; 2015 Jul; 21(13):3052-60. PubMed ID: 25788491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Pdcd4 tumor suppressor in human melanoma cells.
    Vikhreva PN; Korobko IV
    Anticancer Res; 2014 May; 34(5):2315-8. PubMed ID: 24778037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophages/Microglia Represent the Major Source of Indolamine 2,3-Dioxygenase Expression in Melanoma Metastases of the Brain.
    Herrera-Rios D; Mughal SS; Teuber-Hanselmann S; Pierscianek D; Sucker A; Jansen P; Schimming T; Klode J; Reifenberger J; Felsberg J; Keyvani K; Brors B; Sure U; Reifenberger G; Schadendorf D; Helfrich I
    Front Immunol; 2020; 11():120. PubMed ID: 32117271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and clinicopathological significance of microRNA-21 and programmed cell death 4 in malignant melanoma.
    Jiao J; Fan Y; Zhang Y
    J Int Med Res; 2015 Oct; 43(5):672-8. PubMed ID: 26150475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA CASC15 promotes melanoma progression by epigenetically regulating PDCD4.
    Yin Y; Zhao B; Li D; Yin G
    Cell Biosci; 2018; 8():42. PubMed ID: 30013768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma brain metastases have lower T-cell content and microvessel density compared to matched extracranial metastases.
    Weiss SA; Zito C; Tran T; Heishima K; Neumeister V; McGuire J; Adeniran A; Kluger H; Jilaveanu LB
    J Neurooncol; 2021 Mar; 152(1):15-25. PubMed ID: 32974852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An essential role of PDCD4 in progression and malignant proliferation of gastrointestinal stromal tumors.
    Ding L; Zhang X; Zhao M; Qu Z; Huang S; Dong M; Gao F
    Med Oncol; 2012 Sep; 29(3):1758-64. PubMed ID: 21850542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of programmed cell death 4 expression in malignant progression of human nasal inverted papillomas.
    Wang Y; Ding L; Zhang X; Zhao M; Qu Z; Huang S; Zhang Y; Li Y; Gao F
    Med Oncol; 2012 Dec; 29(4):2505-11. PubMed ID: 22359108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma.
    Erdag G; Schaefer JT; Smolkin ME; Deacon DH; Shea SM; Dengel LT; Patterson JW; Slingluff CL
    Cancer Res; 2012 Mar; 72(5):1070-80. PubMed ID: 22266112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct roles of different fragments of PDCD4 in regulating the metastatic behavior of B16 melanoma cells.
    Wang D; Guo S; Han SY; Xu N; Guo JY; Sun Q
    Int J Oncol; 2013 May; 42(5):1725-33. PubMed ID: 23450345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sites.
    Conway JW; Rawson RV; Lo S; Ahmed T; Vergara IA; Gide TN; Attrill GH; Carlino MS; Saw RPM; Thompson JF; Spillane AJ; Shannon KF; Shivalingam B; Menzies AM; Wilmott JS; Long GV; Scolyer RA; Pires da Silva I
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36096531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-resident memory T cells from a metastatic vaginal melanoma patient are tumor-responsive T cells and increase after anti-PD-1 treatment.
    Pizzolla A; Keam SP; Vergara IA; Caramia F; Thio N; Wang M; Kocovski N; Tantalo D; Jabbari J; Au-Yeung G; Sandhu S; Gyorki DE; Weppler A; Perdicchio M; McArthur GA; Papenfuss AT; Neeson PJ
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35550554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical association of programmed cell death protein 4 (PDCD4) with solid tumors and its prognostic significance: a meta-analysis.
    Li JZ; Gao W; Ho WK; Lei WB; Wei WI; Chan JY; Wong TS
    Chin J Cancer; 2016 Nov; 35(1):95. PubMed ID: 27852288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programmed cell death 4 (Pdcd4) expression in colorectal adenocarcinoma: Association with clinical stage.
    Lim SC; Hong R
    Oncol Lett; 2011 Nov; 2(6):1053-1057. PubMed ID: 23049623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of tumor suppressor programmed cell death 4 in endometrioid endometrial carcinomas and clinicopathological significance.
    Liu Y; Sun H; Mao H; Gao M; Tan X; Li Y; Li Y; Muloye GM; Zhang L; Wang X; Wei Z
    Oncol Lett; 2018 Jun; 15(6):9369-9376. PubMed ID: 29805661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.